Takeda Pharmaceutical Co Ltd (FRA:TKD)
€ 25.61 0.16 (0.63%) Market Cap: 40.44 Bil Enterprise Value: 65.50 Bil PE Ratio: 23.27 PB Ratio: 0.97 GF Score: 82/100

Takeda Pharmaceutical Co Ltd Wave 1 Pipeline Opportunity Call - Part 2 Transcript

Apr 06, 2021 / 12:00PM GMT
Release Date Price: €30.49 (-2.40%)
Operator

Good day, everyone, and welcome to the conference call of Takeda Pharmaceutical Company Limited. The conference call today is held based on presentation materials available at the company's website, and may we suggest that you visit the website to see the presentation materials on the screen if you don't yet have printed copies to hand.

Good day, everyone, and welcome to the conference call of Takeda Pharmaceutical Company Limited. (Operator Instructions)

Now we start the conference. Mr. O'Reilly, please go ahead.

Christopher David O;Reilly
Takeda Pharmaceutical Company Limited - Global Head of IR & Global Finance

' -

Hello. Good morning, good afternoon and good evening. My name is Christopher O'Reilly, Global Head of Investor Relations at Takeda. Thank you for joining us today for Takeda's Wave 1 Pipeline Market Opportunity Call Part 2, which is a follow-on from the Part 1 event we did in December of last year.

Before we start, I'd like to remind everyone that we will be discussing forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot